AtasoyN, ErdoganA, YalugI, OzturkU, KonukN, AtikL, UstundagY: A review of liver function tests During treatment with atypical antipsychotic drugs: A chart review study. Prog Neuropsychopharmacol Biol Psychiatry, 31:1255–1260, 2007.
2.
DönmezYE, Özcan Ö, SoyluN, SarıoğluFK, DönmezAS: Management of hepatotoxicity induced by the use of olanzapine. J Child Adolesc Psychopharmacol, 27:293–294, 2017.
3.
EftekhariA, AzarmiY, ParvizpurA, EghbalMA: Involvement of oxidative stress and mitochondrial/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes. Xenobiotica, 46:369–378, 2016.
4.
GaertnerI, AltendorfK, BatraA, GaertnerHJ: Relevance of liver enzyme elevations with four different neuroleptics: A retrospective review of 7263 treatment courses. J Clin Psychopharmacol, 21:215–222, 2001.
5.
PerumpailBJ, LiAA, JohnN, SallamS, ShahND, KwongW, CholankerilG, KimD, AhmedA: The role of Vitamin E in the treatment of NAFLD. Diseases, 6:86, 2018.
